Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07521904 · ClinicalTrials.gov registry record

Naturopathic Approaches to Ulcerative Colitis

A clinical trial, sponsored by National University of Natural Medicine.

Not yet
Registry status
50
Enrollment target

NCT07521904: Clinical Trial study, sponsored by National University of Natural Medicine.

NCT07521904 is a clinical trial that has not yet begun recruiting, run by National University of Natural Medicine. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07521904 has not yet begun recruiting, sponsored by National University of Natural Medicine.

NOT YET RECRUITING
Registry status
50 participants
Enrollment target

Study Summary

Ulcerative colitis (UC) is a long-term condition that causes inflammation in the large intestine. People with UC often have symptoms such as diarrhea, abdominal pain, and fatigue. These symptoms can come and go over time and can have a major impact on daily life. Although there are many medical treatments available, some patients do not respond well, experience side effects, or prefer to avoid long-term use of medications that affect the immune system. Because of this, many people with UC seek care from naturopathic doctors. This study aims to better understand how naturopathic care is used to treat UC and whether patients experience changes in their symptoms over time. In this study, adults with UC who are already receiving care from a naturopathic doctor will be followed for 12 weeks. The treatments will not be standardized; instead, each naturopathic doctor will provide individualized care based on their usual practice. Participants will complete a questionnaire that measures UC symptoms at the start of the study and again after 12 weeks. The study will compare symptom scores before and after treatment. Researchers will also collect information about the types of treatments used and any side effects or adverse events. This is an observational study, meaning there is no comparison group and no changes are made to participants' usual care. The goal is to gather early information about naturopathic care for UC and to help guide future, more rigorous studies.

Primary Outcome

There are over 30 patient reported outcomes (PRO) instruments in use for patients with IBD.14 The oldest and most widely used is the Patient-Modified Simple Clinical Colitis Activity Index \[P-SCCAI\], a validated, non-proprietary patient-reported outcome measure for ulcerative colitis. The P-SCCAI is a patient-worded version of the Simple Clinical Colitis Activity Index and includes six symptom domains: stool frequency (day and night), urgency, rectal bleeding, general well-being, and extra-int

Interventions

  • OTHER Naturopathic medicine

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-04-01
Est. Completion 2027-10-01

What is known before NCT07521904 opens enrollment

NCT07521904 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Naturopathic medicine is the first listed.

NCT07521904 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07521904 about?

NCT07521904 is a clinical study titled "Naturopathic Approaches to Ulcerative Colitis". Ulcerative colitis (UC) is a long-term condition that causes inflammation in the large intestine. People with UC often have symptoms such as diarrhea, abdominal pain, and fatigue. These symptoms can come and go over time and can have a major impact on daily life. Although there are many medical trea...

What is the current status of trial NCT07521904?

This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-04-01. Estimated completion is 2027-10-01.

What interventions are being tested in trial NCT07521904?

The interventions under investigation include: Naturopathic medicine (OTHER).

Who is sponsoring clinical trial NCT07521904?

This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07521904, the US trial registry maintained by the National Library of Medicine. NCT07521904 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.